Corixa Corp About
Corixa: Corixa is a developer of immunotherapeutics with
a commitment to treating and preventing autoimmune diseases, cancer and infectious
diseases by understanding and directing the immune system. Corixa is focused on
immunotherapeutic products and has a broad technology platform enabling both fully
integrated vaccine design and the use of its separate, proprietary product components
on a standalone basis. Corixa currently has multiple programs in clinical development,
including several product candidates that have advanced to or through late stage
clinical trials. The company is a product development company with multiple
product candidates, many in late-stage human clinical trials. CRX-675, Vaccine for TB, Vaccine for Lung
Cancer, Her-2/neu for breast cancer, vaccine for leishmaniasis, MPL adjuvant for
allergies, MPL adjuvant for herpes, MPL for HPV. More
on Corixa:
Key
Statistics for Corixa
Basic
Chart for Corixa